Research Technologies

Roche is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.

Partnering opportunities we are looking for:

Novel modalities and enabling technologies to expand the druggable target space
Targeted or intracellular delivery
Artificial intelligence for target and drug discovery
Genomic Medicine platforms

Example partnerships

Manifold Bio
Research collaboration to develop multiple next-generation brain shuttles for neurological diseases leveraging Manifold's AI-guided direct-to-vivo platform
C4T
Expanded collaboration agreement to advance research in the emerging degrader-antibody conjugate (DAC) modality. By combining antibody-drug conjugation (ADC) and targeted protein degradation (TPD) the partners seek to develop a new way to treat cancers that leverages both the specificity and catalytic efficiency of degraders with the delivery capabilities of ADCs.
Nvidia
Partnership to accelerate R&D by using AI and computing technology to better understand disease biology and develop novel therapeutics
Orionis Biosciences
Collaboration to discover and develop novel small molecule medicines, including molecular glues, for challenging targets in major disease areas, including oncology and neurodegeneration.
Recursion
Research collaboration with Roche and Genentech to use machine learning and high content screening methods at scale to map complex biology in neuroscience and oncology
Vividion Therapeutics
Research collaboration to discover and develop compounds targeting novel E3 ligases and a range of oncology and immunology therapeutic targets based on Vividion's covalent chemistry

Explore collaboration opportunities

Connect with our partnering experts to start the conversation.

Reach out

More Pharma partnering areas

View all areas

Digital and data

Innovation

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Immunology

Innovation

Leading the way to advance science in inflammatory and autoimmune diseases.

Infectious Diseases

Innovation

We are advancing innovation to combat infectious diseases like HBV, influenza and MDR.

Neurology

Innovation

We focus on advances for neurodegenerative, psychiatric and neurodevelopmental disorders.

Oncology and Haematology

Innovation

We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.

Ophthalmology

Innovation

We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.

Cardiovascular, Renal & Metabolic Disease

Innovation

Roche is committed to making a contribution to areas of huge unmet need and societal burden through transformative science like in cardiovascular and metabolic diseases

Discover more